On January 5, 2022 with a reversal of a “2013 Health Canada policy that prevented “a letter of authorization for a new drug that is or that contains a restricted drug” the floodgates opened for psychedelic drug development companies with Health Canada’s Special Access Program (SAP)
For those readers who are just tuning in to the psychedelic renaissance or for those who need a refresher it is not surprising news to seasoned psychonauts that these powerful medicines have curative properties.
All this change in policy can’t seem to happen fast enough because there has been a shift toward recreational drug users taking microdoses of LSD and mushrooms to improve their wellbeing and mental health during the pandemic.
The goal of Measure 109 is to make psilocybin, the chemical compound found in magic mushrooms, legal for therapeutic use. This would make Oregon the first state in the country to do this.
The non-ordinary appears to be becoming the ordinary state of discourse in politics this week – in the space of two days Francis Collins, director of the National Institute of Health (NIH) copped to the fact that psychedelics…
Can access to psychedelics and psychedelic therapy or access without the fear of criminal repercussions help folks overcome the stress, anxiety, depression and trauma associated with the pandemic?